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Introduction 
An important and recurrent concern in economics has been to understand to what extent science 
influences technological progress. This literature has shown that knowledge flows from 
universities and public research centres make a substantial contribution to industrial innovation 
and, consequently, to public welfare.
1  
 
More recent research suggests that the links to basic research by industrial firms have 
dramatically increased in the last decade. There is evidence of rising university spin-offs 
(Jensen and Thursby, 2001; Thursby and Thursby, 2002), university-industry collaboration 
(Liebeskind  et al, 1996; Darby and Zucker; 2001; Zucker et al, 2001; 2002), mobility of 
university researchers (Kim et al, 2005), science-linkage in private patents (Narin et al, 1997; 
Hicks et al, 2001), and so forth. Narin et al (1997) report a threefold increase in the number of 
academic citations in industrial patents in the United States through the mid 1990s.
2 These 
patterns suggest an increased opportunity for innovation offered by linking to science and 
scientific institutions.  
 
In spite of this growing evidence about firms connecting to science, our understanding at the 
firm level about how knowledge transfers occur through these links and how they affect 
industrial innovation remains unclear. The main incentive for enterprises to engage in industry-
science links (ISL) is to access scientific know how and knowledge. For private organizations 
to create and maintain such links to science, ultimately, this knowledge should increase the 
productivity of own internal research (Evenson and Kislev, 1976; Gambardella, 1992; 
                                                 
1 The importance of academic research for industrial innovation has also been corroborated in studies based on 
industrial survey and patent statistics (Mansfield, 1991, 1995; Cohen, Nelson and Walsh, 2002). 
2 Narin, Hamilton, Olivastro (1997), Branstetter (2004), and Van Looy et al (2004), have all confirmed an 
increasing citation to academic publications in patents   3
Cassiman et al., 2001).   The role and importance of science will be affected by industry 
factors, but also by firm and invention level factors.  
 
In this article, we shed some light on the debate on the importance of ISL by looking at the 
“diversity” of linkages to science employed by Flemish firms and their relationship to 
innovative performance.  Combining patent, publication and innovation survey information for 
these firms,  a wide variety of industry science link indicators can be considered:  i) cooperative 
R&D agreements with public research centers and universities, ii) use of public information 
sources – universities, public research centers, conferences, meeting and publications – to 
innovate, iii) citation to scientific literature in patents of the firm, and, iv) involvement in 
scientific publications by the firm.  
 
A first contribution of the paper is to show the diversity in ISL being used by firms,  suggesting 
the need to look beyond a single “silver-bullet” industry-science link, to include the full 
portfolio of industry science links.  A second contribution of this paper consists in evaluating 
whether these different types of ISL enhance industrial innovation and economic performance 
of the firms using ISL. Two types of analysis are presented. First, we relate linkages to science 
to the different indicators of innovation and economic performance at the firm level (with 
performance measured as turnover due to innovation and turnover due to market introduction as 
reported in the CIS 1998-2000 data).  Second, we delve further into the micro-level connections 
between science and innovation performance, focusing on the invention (i.c. patent) level. For 
this we restrict the sample to patenting firms and compare the differences in patent quality 
(forward citation) between patents with and without science linkages.  We also return to the 
firm level, by comparing the quality of patents (forward citations) of firms with science 
linkages vis-à-vis patents of other firms.  We thus provide an evaluation of the effectiveness of   4
the science-linkages to enhance technological performance by looking at the quality of private 
inventions.   
 
The paper is organized as follows. Section I presents a summary of the literature and reviews 
previous empirical work on the value of science for industrial innovation. While our 
contribution is intended to be rather descriptive, the review does lead to the formulation of our 
main hypotheses. Section II describes our data and the methodology. Basic descriptives are 
presented on the frequency of ISL, and the adoption of ISL by firms across various types of 
industries. Section III evaluates the relationship between ISL and firms’ innovation 
performance. The final section concludes and identifies some preliminary policy implications 
based on our research. 
 
I.  The value of Science  
The value of science for innovation and growth has been demonstrated using a diverse set of 
methodologies. In large sample research Griliches (1979) and Adams (1990) have shown the 
important contribution of basic research (e.g. public research expenditures and scientific 
publications) to economic growth. Complementary research based on surveys has provided an 
alternative estimation of the contribution of basic research for industrial innovation and 
economic performance. In a survey of 76 U.S. firms in seven industries, Mansfield (1991) 
found that 11% of new product innovations and 9% of process innovations would not have 
been developed (without substantial delay) in the absence of recent academic research; these 
innovations represented respectively 3% and 1% of sales. Both the 1983 Yale Survey and the 
1994 Carnegie Mellon Survey of R&D have also shown the relevance of university research for 
industrial innovation and provide some insight as to the importance of different channels 
(Cohen  et al, 2002). According to the 1994 Carnegie Mellon Survey, American firms   5
considered publishing by universities and patenting amongst the most important sources of 
knowledge for the innovation process.
3   In a survey of Europe’s largest industrial firms, 
Arundal and Geuna (2004) find that public science is amongst the most important sources of 
technical knowledge for the innovative activities.   Evidence from the European community 
innovation surveys (CIS) indicates that 31% of firms that develop products or processes that are 
new to the market is an important source of information for the innovation process, compared 
to a mere 4% of all innovating firms who find these information sources important in general 
(EC-DGECFIN, 2000). Therefore, it seems that science is more important as a source of 
knowledge for innovation when innovations new to the market are developed. 
 
The management literature has tried to open the firm’s black box on how science linkages can 
improve the productivity of firm’s internal research.  Different mechanisms have been 
associated with this beneficial effect of science on innovation performance of firms. First, 
investment in science generates absorptive capacity and a better understanding of scientific 
research. As a result, the firm more easily identifies and integrates external information, 
enhancing the productivity of internal research (Cohen and Levinthal, 1989 and 1990; Arora 
and Gambardella, 1990) Second, Cockburn and Henderson (1998) argue that returns to science 
are exploited through economies of scope across different product lines. They trace these 
effects across therapeutical classes within the same pharmaceutical company. A third 
mechanism advanced by Fleming and Sorenson (2004) is that science serves as a map of the 
technological landscape and directs private research towards the most promising technological 
venues avoiding thereby wasteful experimentation.
4 Finally, Stern (1999) shows that the 
                                                 
3 The results indicate that the key channels through which university research impacts industrial R&D include 
published papers and reports, public conferences and meetings, informal information exchange, and consulting. 
4 According to Fleming and Sorenson (2004), scientific knowledge differs from that derived through ‘local’ search 
within the firm -which is closely related to firms’ prior research activities-, namely because the scientific 
endeavour attempts to generate and test theories and fundamental ideas, whereas local search is focused on finding 
new technological solutions within a predetermined pool of knowledge.   6
adoption of pro-publication incentives for employees helps firms attract high quality academic 
researchers whose economic value might frequently be higher than their actual remuneration. 
Researchers looking for academic reputation, may want to pursue research projects leading to 
publications and are, therefore, likely to accept lower salaries in exchange of permission to 
keep up with scientific research. These researchers provide value along two dimensions: they 
not only generate important labor costs reductions and consequently higher productivity of 
internal research, but they also constitute a bridge with the scientific or academic world.   
 
A growing literature has tried to empirically assess the impact of ISLs on firm performance 
(e.g. Audretsch and Stephan, 1996; Zucker et al 1998; Cockburn and Henderson, 1998). Using 
university collaboration as an ISL, these papers seem to support the hypothesis that these links 
boast internal R&D investment (Adams et al, 2000), innovation productivity and sales 
(Belderbos et al, 2005).
5 While they provide little explanation about the process through which 
science affects private innovation, the studies have found that science involvement and ties with 
academic star scientists lead to more patented technology (Henderson and Cockburn, 1996; 
Zucker  et al, 2002; Cockburn and Henderson, 1998); more “important” patents: i.e. 
international patents (Henderson and Cockburn, 1996); and higher average of quality adjusted 
patenting at the firm level (Zucker and Darby, 2001; Zucker et al, 2002).  
 
The work of Cockburn and Henderson (1998) has shown that absorptive capacity is also 
affected by the closeness of the firm to scientific communities (Cohen and Levinthal, 1989; 
Kamien and Zang, 2000). Using data on co-authorship of scientific papers for a sample of 
pharmaceutical firms, they show that firms connected to science show a higher performance in 
                                                 
5 For instance, Lööf and Broström, (2004) have found complementarities between internal R&D and collaboration 
with universities: the average R&D firm that cooperates on innovation with universities spend more money on 
R&D and has a larger propensity to apply for patents compared to an almost identical R&D firm which has no 
such collaboration.   7
drug discovery and that this connectedness is closely related to the number of star scientists 
employed by the firm.
6 Zucker et al (1998) and Darby and Zucker (2001) found that the 
location of top star scientists predicts firm entry into biotechnology (by new and existing firms) 
both in the United States and Japan. Darby and Zucker (2005) find similar evidence that firms 
enter nanotechnology where and when scientists are publishing breakthrough academic 
articles.
7 In addition, collaborations between particular university star scientists and firms had a 
large positive impact on firm research productivity, increasing the average firm's biotech 
patents by 34 percent, products in development by 27 percent, and products on the market by 8 
percent (Darby and Zucker, 2001).  
 
In spite of such apparent benefits, the adoption of science by private firms remains limited and 
the benefits of science links seem hard to trace at the firm level as evidenced by different 
studies. Due to the highly specific nature of the know-how involved, only a select set of firms 
within specific industries tend to show strong interest in the scientific know-how offered by 
universities or other research institutes. Not surprisingly, in a survey based study on 38 
Advanced Technology Projects, Hall et al (2001) found that projects with university 
involvement tend to develop new knowledge and therefore experience more difficulty and 
delay but also are more likely not to be aborted prematurely.
8 As a result, R&D managers often 
resent dealing with such joint projects (see Cassiman et al. 2009). Furthermore, linking with 
science is not costless as it requires the adoption of new organizational practices and the 
                                                 
6 Differences in the effectiveness with which a firm is accessing the upstream pool of knowledge correspond to 
differences in the research productivity of firms of as much as 30%.  
7 Furthermore, they report a similar pattern previously reported in biotech: breakthroughs in nanoscale science and 
engineering appear frequently to be transferred to industrial application with the active participation of discovering 
academic scientists. 
8 In a sample of 62 U.S. university licensing officers, Jensen and Thursby (2001) find that over 75% of the 
inventions licensed by these universities were in a very early, or embryonic stage. Further, 71% of the inventions 
licensed required cooperation between the professor and the licensing firm in order to commercialize a product 
successfully. Relying on the CIS for Belgium, Veugelers and Cassiman (2005), find that cooperation with 
universities is formed whenever risk is not an important obstacle to innovation.   8
recruitment of qualified scientists (Gambardella, 1994; Cockburn et al, 1999). Given these 
obstacles, firms will carefully assess the expected costs and benefits from developing ISL.  
 
While most studies have focused on a particular type of ISL – often in pharmaceuticals, 
biotechnology or nanotechnology, we believe that a variety of types of ISL are viable 
conditional on the underlying industry, firm and technological conditions. Nevertheless, firms 
interested in ISL are expected to access science through different complementary modes as the 
marginal cost of investing in additional modes of linking with science is lower once the cost of 
organizing accordingly has been sunk. 
 
In what follows, we will first document the diversity of ISL that firms can develop. As argued, 
we expect a certain degree of complementarity between these different ISL measures. For 
example, we expect that firms actively engaged in publishing their research are likely to have 
collaborative agreements with universities and find publicly available knowledge important for 
their innovation process. Second, we will examine the relative performance of these different 
ISL. While the overall performance of ISL is expected to be positive, little is actually known 
about the relative performance of different types of ISL. Furthermore, we will delve into the 
firm and examine the effect of ISL at a more disaggregated level: the invention (i.c. patent) 
level. We expect that at the invention level ISL would also positively impact performance, 
affecting the quality of inventions, as proxied by the citations received by these patents.   
Previous empirical research has shown that patents of universities are broader in scope and 
cited more frequently than private patents because they rely on more fundamental knowledge 
suggesting that public science is an important input for the innovative activities of firms (e.g. 
Jaffe et al, 1993; Henderson et al, 1998; Narin et al., 1997). Yet, there is little evidence about   9
the effectiveness of science to explain the quality of private patents (see Cassiman et al. (2008) 
for a more elaborate analysis at the invention level). 
 
 
II.  The diversity of Linkages to Science 
A first objective of our analysis is to assess the heterogeneity in industry science links used by 
firms.   To this end, we use data on firms’ research strategies from the Third Community 
Innovation Survey (1998-2000) conducted in Belgium in 2000.
9 A mail survey was sent out to a 
representative sample of manufacturing firms and the intended respondent was the CEO or the 
R&D manager of the establishment. A total of 1471 responses were obtained from the 2726 
surveys sent, resulting in a response rate of 54%. In this paper, we limit our sample to the 842 
manufacturing firms that are engaged in innovation activities.
10 We complemented the survey 
results with patent and publication data of the firms.  This allowed constructing the following 
measures of ISL: 
i)  A dummy variable (0/1) indicating whether the firm had at least one cooperative 
agreement in R&D with universities or public research centers. 
ii)  A dummy variable (0/1) indicating whether the firm considers public information a 
very important source for innovation. Firms scored the importance of public 
information – (i) information from universities, (ii) public research institutions, or (iii) 
conferences, meetings or publications – on a scale from “0” (unimportant) to “3” (very 
important). Firms scoring “3” (very important) on one of these information sources are 
coded “1” in our measure of the importance of public information for the innovation 
                                                 
9 Since 1994 the European Community organizes every 4 years the EU wide “Community Innovation Survey” 
(CIS) on innovation practices by firms. The survey is organized by Eurostat, the statistical agency of the EU, but 
every member state is responsible for organizing the actual survey in its territory. The survey provides quantitative 
and qualitative information about the firms’ innovation activities. Questions range from internal and external R&D 
activities, R&D cooperation partners, sources of information of the innovation process, objectives of the 
innovation process, to questions about the effectiveness of protection measures of knowledge, etc. The survey has 
been widely used in recent years to examine innovation practices of firms. 
10 These firms had successfully introduced new products or processes from 1998 to 2000, or, claimed to be actively 
engaged in innovation activities during those years and projects failed or did not produce any outcomes yet.   10
process. 
iii)  A dummy variable (0/1) indicating whether the firm is simultaneously engaged in a 
cooperative agreement in R&D with universities or public research centers, and, 
considers public information a very important source for innovation (effectively this 
measure is an interaction between the two previous measures). 
iv)  A dummy variable (0/1) indicating whether the firm has been engaged in publication 
activity. The measure takes the value of “1” if the firm published at least one scientific 
article between 1990 and 1995, predating the survey years and any patents of the firm 
(see below). Data on publications is collected from the ISI-Web of Knowledge database 
using the affiliation of the authors. A publication is considered scientific if it is found in 
the ISI Web of Knowledge and one of the authors is affiliated to the firm. 
v)  A dummy variable (0/1) indicating whether the firm has patents that contain references 
to scientific papers. These references are termed scientific non-patent references 
(NPR)
11. An NPR is considered scientific if it is found in the ISI-Web of Science.  We 
collected all the patents of our CIS-3 firms in the European patent database (EPO 
ESPACE-B database) with grant dates between 1995 and 2001. These patents fall 
within the same time frame as the CIS survey. A total of 1186 patents were granted to 
79 firms reported in CIS-3. 
 
Tables 1 and 2 report the distribution of firms across the different measures of ISL and across 
industries. The first finding that emerges from these tables is the high number of firms without 
any ISL. About 75% of innovating firms do not have any linkage to science through 
                                                 
11 Some researchers consider (e.g. Jaffe et al., 1993) patent and non patent citations as a “noisy signal” of 
knowledge flows, with examiners adding much of the noise.
  As patent and non patent references are issued from 
the examiner revision of the prior art in the European Patent Office, citations may rarely reflect or coincide with 
the science used by inventors. Care should therefore be exercised when interpreting the citation results as measures 
of direct knowledge flows. Nevertheless, some evidence exists that scientific NPRs are more likely inventor given 
compared to regular patent references (see Alcacer and Gittelman, 2006).   11
cooperative R&D agreements nor find public information very important for their innovation 
process. Not surprisingly, Table 2 shows that the low R&D intensive industries have the highest 
percentage of firms not having any connection to science (82%) while the opposite is true in the 
high R&D intensive industries, confirming the importance of technology and industry 
characteristics driving ISL.
12   Within the high R&D intensive industries, 25% of firms are 
engaged into cooperation with public institutions, 33% consider the use of public information 
as very important for innovation; while 16% declare to be engaged in both strategies. These 
results are related to the underlying industry effects as seen in Table 1 where Electronics and 
Medical and precision instruments followed by Chemicals (including pharmaceuticals) score 
high on all types of ISL. Some interesting industry variation in the relative use of ISL emerges 
across industries from Table 1 though. Firms in Wood, printing and publishing industries or in 
Glass/Ceramics find public information sources relatively more important compared to 
engaging in cooperative agreements. Contrarily, firms in the Medical and precision instruments, 
Electronics or Vehicles business rely more on cooperation than on public information for their 
connections to science. Only very few firms report citations to the scientific literature in their 
patents. They represent less than 3% of the population of manufacturing firms in CIS casting 
some doubt on the relevance of such indicators for understanding links to science in the 
population of firms. If we consider only the population of patenting firms, 24% (19 firms out of 
79) of these firms report an ISL in their patents. 
 
                                                 
12 We follow the criteria used by the OECD (OECD Science and Technology, 2001). Manufacturing industries are 
classified in three different categories of technological intensity: high technology, medium-technology industries 
(grouping medium-high technology and medium-low technology) and low technology. High-technology industries 
include (ISIC. 3): Aerospace, Office & computing equipment; Drugs & medicines, Radio, TV & communication 
equipment. Medium Technology groups the two classes distinguished by OECD: Medium-high-technology 
industries (Scientific instruments, Motor vehicles, Electrical machines excl. Communication equipment, 
Chemicals excl. drugs, Other transport, and Non-electrical machinery) and Medium-low-technology industries 
(Rubber & plastic products, Shipbuilding & repairing, Other manufacturing, Non-ferrous metals, Non-metallic 
mineral products, Metal products, Petroleum refineries & products, Ferrous metals). Low-technology industries 
are: Paper, products & printing; Textiles, apparel & leather; Food, beverages & tobacco and Wood industries. 
   12
Figure 1 attempts to map the overlap between different types of ISL. We classify firms 
according to whether they cooperate with universities, find public information very important, 
or, have patents that refer to scientific publications, or any combination of these ISL. While we 
might have expected some complementarity between the different types of ISL, the diversity 
we actually find at the firm level is striking. At the sector level there seems to be substantial 
correlation between different types of ISL as shown by Tables 1 and 2. But at the firm level we 
find considerable diversity. Only 5 firms combine all three types of ISL (and 4 of those firms 
are also involved in publishing). Interestingly, 7 firms that do not report any other ISL appear 
as firms with scientific NPRs in their patents; Out of these 7 firms 5 belong to the medium 
R&D intensive industries. Only 45 firms use both cooperation in R&D agreements with 
universities and public information as ISL. Out of these 45 firms only 5 report citation to 
science in their innovation outputs measured by patents. Similarly, the majority of firms with 
cooperative R&D agreements with the university (60 out of 100) and firms that find public 
information very important (74 out of 121) do not have any other type of ISL. Very few firms 
(8) are directly involved in open science through publication, but more surprisingly, 5 of these 
firms are found in the medium low R&D intensive industries. These simple descriptive 
statistics – while based on a rather small sample – do corroborate the heterogeneity that exists 
in the ways to access scientific knowledge. At the same time our results reveal that each 
individual ISL measure might provide additional information about firms linking to science.  
 
III.  Performance of Linkages to Science 
In this section we focus the analysis on whether and which type of ISL enables firms to achieve 
higher innovation and economic performance. Following the literature previously exposed, we 
expect that firms connected to science develop a comparative advantage in the production of 
innovation and notably, in the production of breakthrough innovation. ISL facilitate the   13
absorbing and understanding of fundamental knowledge, allow firms to follow new discoveries, 
upgrade internal technological competences, and detect new opportunities for industrial 
innovation. All of these effects of ISL are expected to improve the productivity of applied 
research. 
 
We present two levels of analysis. First, we relate ISL to the indicators of innovation and 
economic performance at the firm level reported in the CIS-3 data (section III.A).  The key 
measure of innovation we will use is the percentage of innovations that are new to the market. 
The indicators of economic performance are the percentage of turnover due to innovations 
introduced in the past 2 years, and, the percentage of turnover due to new market introductions 
during those past 2 years. Second, we restrict our analysis to the 79 firms with patents and 
analyze the effect from ISL on the quality of patents, both at the level of the invention (i.c. the 
patent) and at the level of the patenting firms (section III.B).    
 
III.A.   Science linkages and Economic Performance  
Table 3 displays the means for the R&D intensity, the number of employees, sales, and the 
measures of innovation and economic performance broken down by ISL. The percentage of 
firms that declare innovation new to the market is reported in the last row. Not surprisingly, 
firms with at least one ISL (column 2) are larger in turnover, have more employees and have 
high R&D intensity. These firms can more likely cover the sunk cost of becoming science 
linked. At the same time – corroborating the hypothesis advanced in the literature – firms with 
ISL have a higher percentage of sales from new or improved products (innovation turnover 
ratio) and a higher percentage of sales from innovative products that are new to the market (as 
opposed to new to the firm). Firms that have science linkages also show a higher frequency of 
innovations new to the market (47% versus 38%). When comparing different science linkages,   14
firms declaring to cooperate with public institutions and also declaring the use of public sources 
of information as very important (column 5) have a high frequency of introducing innovations 
new to the market (44%), but the group of firms having scientific references in their patents 
(column 7) appears as having the largest percentage of firms having introduced radical 
innovations (63%). Firms with this ISL also display the highest innovation turnover ratio and 
turnover due to new market introductions, but these firms are also larger and have a 
significantly higher R&D intensity. While firms with different ISL do display significant 
differences in size and R&D intensity, the differences in innovation output is not significant.
13  
 
The correlation matrix in Table 4 offers additional insights on the correlation of ISL with 
respect to performance. Consistent with our finding about the diversity in ISL of firms, we find 
that having a link (column 1) has the highest correlation with the innovation turnover ratio, the 
new to market innovation turnover ratio and the new to market introduction indicator, while no 
one specific link seems to account for this positive effect.  
 
Overall, we confirm the fact that ISL and firm innovation performance are positively related. At 
the same time, no single ISL seems to drive this result. Rather, firms can affect their 
(innovation) performance through engaging in various types of ISL, reinforcing the fact that we 
found substantive heterogeneity across firms in ISL. 
 
III.B.  Science linkages and quality of patents 
We now turn to the analysis of the impact of industry science links on the quality of firm’s 
inventions, as proxied by the quality of the firm’s patents.   As measure of patent quality we use 
the number of forward citations received.  Past research has shown that the number of citations 
                                                 
13 Small sample size is clearly an issue to obtain robust results.   15
a patent receives is highly correlated with its technological importance and social value 
(Trajtenberg, 1990). Moreover, forward citations are correlated with the renewal rate of patents, 
the estimated economic value of inventions and patent opposition (Lanjouw and Schankerman, 
1999; Harhoff et al, 1999; Hall et al, 2000).  
 
We have also computed two additional quality indicators related to the technological impact of 
the patent based on forward citations: generality of the technology and geographical dispersion 
of the technology. A high generality score indicates that the patent had a broad technological 
impact where it influenced subsequent innovations in a broad set of technological fields (Hall et 
al, 2001). This indicator is build as a Herfindahl index (Jaffe et al, 1993; Hall et al, 2001): 
2
1 ∑ − =
i n
i ij s generality , where sij denotes the percentage of citations received by patent j that 
belong to patent class i, out of ni patent classes.
14 If the patent receives all of its future citations 
from a single patent class, the index is equal to zero. A higher generality index implies a more 
technologically diverse the set of patents that cite the focal patent. The index of geographical 
dispersion is built in a similar way:
2
1 ∑ − =
i n
i ij s dispersion al geographic , where sij denotes the 
percentage of citations received by patent j that come from country i, out of ni countries. The 
index is based on the country location of the inventors. A higher index means that future 
citations come from a more diverse set of countries, which relates to the notoriety of the 
technology.  
 
We test the impact of industry science links on patent quality at two levels: the invention level 
and the firm level.  For the invention level, we compare patent quality – number, technical and 
geographical scope of citations to the patent - of patents with scientific NPRs, as our measure 
of industry science link at the invention level,  to the quality of patents without scientific NPRs. 
                                                 
14 Patents are classified according to a system of technological patent classes (IPC-codes).   16
For the firm level, we compare the quality of patents of firms with ISL (such as publishing, 
cooperating or scanning public knowledge) to the quality of patents of firms without ISL.  
 
The analysis is performed on the 79 Flemish firms which hold granted patents from the 
European Patent Office with grant dates between 1995 and 2001.  These 79 firms together 
account for 1186 patents.  The forward citations to these patents – the number of citations 
received by the patent from future patents – are computed until 2003.  
 
The breakdown of patent quality measures across the firms distinguished according to the 
different types of ISL they use, is reported in Table 5a.   As expected, firms having at least one 
ISL to scientific communities report a higher likelihood of their patents being cited (dummy for 
having at least one forward citation), their patents appear more general in scope (are cited more 
across different technology classes) and have a higher geographical dispersion. However, the 
difference in means is significant (at 10%) only for geographical dispersion and the frequency 
of being cited at least once (dummy for forward citation). Firms that cooperate or use public 
sources of information report on average 0,69 and 0,71 citations to their patents respectively 
and firms involved directly in science through own publication activity report an average 0,72 
forward citations to their patents. These effects are only marginally significant. But they seem 
to confirm the superior performance in terms of patent quality from firms engaged in science 
linkages. No particular type of ISL seems to stand out in this relation. 
 
Table 5b reports the comparison of patents with scientific references (NPRs) to patents without 
scientific references.   Contrary to our expectations, we find that patents without NPRs are more 
likely to be cited (33% versus 24%) and have a higher mean of forward citations.  But patents 
with NPRs are more general and more geographically dispersedly cited. Although the results   17
are on a small sample and not robust
15, they suggest that while patents with scientific NPRs 
protect more general technologies, more applied patents – patents without scientific NPRs – 
actually capture the value for the firm. Patents citing a scientific publication appear to cover 
more fundamental knowledge and they are therefore more likely to be cited across a broad 
range of technology classes and across different countries. But this kind of patent is not 
different from the rest of patents based on the average count of citations received. 
 
Finally, in Table 6 we combine the invention and the firm level of analysis.  Controlling for 
firm level ISL, we compare the quality of patents with and without NPRs.   In the first panel we 
consider only firms with scientific publications and look at the quality of patents with and 
without scientific NPRs (cols (1) and (2)). We confirm the results from Table 5b that patents 
with scientific NPRs are more general and their citations are more geographically dispersed, but 
these patents are less likely to be cited. However, and more interestingly, comparing the 
forward citations of patents without NPRs of these firms that publish with patents without 
scientific NPRs of other firms that have no publications (cols (2) and (4)), we find that the 
patents of publishing firms are more likely to be cited and receive more citations (0,36 versus 
0,27) and (0,72 versus 0,55) respectively. Our interpretation is that firms with scientific 
publications not only are more likely to have patents with scientific NPRs, but also have higher 
quality applied patents (patents without scientific NPRs) thanks to their more fundamental 
knowledge of the technology. This result is confirmed in the panels below for firms that 
cooperate in R&D with public research institutions, or, for firms that consider public sources of 
information very important. We conclude that controlling for the firm level science links when 
evaluating patent quality is crucial to pick up the innovation performance effect of these science 
links – the higher new to market innovation content of these innovations. Patents from firms 
                                                 
15 Only for generality and the likelihood of receiving a forward citation, these differences are significant, but only 
at the 10% level.      18
engaged in ISL will be more valuable and are more likely to lead to innovations that are new to 
the market. 
 
IV.  Conclusions   
This paper examines the diversity of the types of links to science and their association to 
innovation performance for a sample of Flemish firms. We identify different ways to access 
scientific knowledge, using information from the Eurostat, Community Innovation Survey, and 
add additional measures on the use of science by firms by analyzing publication data and 
citations to science in these firms’ patents.  
 
We confirm previous findings in the literature that firms with science linkages seem to enjoy a 
superior innovation performance. However, contrary to our expectation we find that different 
types of ISL are not complementary.  While firms engage in different forms of ISL, the positive 
effect of these links cannot be related to a particular type of linkage.    
 
Furthermore, the causality does not necessarily run as expected. Patents that directly cite 
science are actually less likely to be cited, presumably because of their more basic nature. But if 
cited, these citations are more likely to come from a broader set of technologies and 
geographies, consistent with their more basic nature. Patents from firms that are actively 
engaged in ISL at the firm level through cooperative R&D agreements, publishing or scanning 
public information sources are more highly cited, especially those that do not refer to science 
directly. We speculate that firms with active ISL develop more basic technologies and have a 
better understanding of the fundamental technologies. As a result their regular patents (i.e. not 
directly linked to science) are also more valuable. 
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While our sample of firms is limited, we can nevertheless provide some policy suggestions.  
Our results indicate that several indicators need to be tracked to obtain a representative picture 
of the ISL activity of a firm, an industry and a country. In addition, to bring out the true effect 
of these links, firm and invention level indicators need to be interacted. Furthermore, our results 
indicate that further research is needed to understand the process of how the link with science 
affects the productivity of applied research internal to the firm. Understanding this process 
would open the door to develop more relevant measures related to the effect of science on 
innovation at the micro-level. 
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Figure 1: Overlap between Types of ISL 
Firms with scientific NPR 
7 (2 involved in scientific 
publication) 
Use of public sources of 
information 
74 
Cooperation with public institutions 
60 (2 involved in scientific 
publication) 
40 
Firms without linkage to science  
649 (1 involved in scientific publication) 
2 
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Food and tobbaco 74 59 79,73% 9 12,16% 8 10,81% 2 2,70% 3 4,05% 0 0,00% 0 0,00%
Textiles 68 55 80,88% 9 13,24% 8 11,76% 4 5,88% 2 2,94% 0 0,00% 0 0,00%
Wood, printing, publishing 82 69 84,15% 3 3,66% 9 10,98% 1 1,22% 4 4,88% 1 1,22% 0 0,00%
Chemicals, coke, petroleum 85 54 63,53% 14 16,47% 16 18,82% 7 8,24% 10 11,76% 5 5,88% 3 3,53%
Rubber and plastic 84 63 75,00% 13 15,48% 14 16,67% 7 8,33% 10 11,90% 1 1,19% 1 1,19%
Glass, ceramic 39 31 79,49% 3 7,69% 4 10,26% 1 2,56% 2 5,13% 1 2,56% 1 2,56%
Metals, metallurgy 121 91 75,21% 14 11,57% 19 15,70% 7 5,79% 15 12,40% 3 2,48% 3 2,48%
Machinery, equipment 114 85 74,56% 14 12,28% 16 14,04% 6 5,26% 16 14,04% 4 3,51% 0 0,00%
Electronics 56 33 58,93% 14 25,00% 11 19,64% 4 7,14% 9 16,07% 2 3,57% 0 0,00%
Medical and precision instruments 18 8 44,44% 4 22,22% 8 44,44% 4 22,22% 4 22,22% 2 11,11% 0 0,00%
Vehicles 62 48 77,42% 10 16,13% 5 8,06% 1 1,61% 3 4,84% 0 0,00% 0 0,00%
Furniture 39 34 87,18% 3 7,69% 3 7,69% 1 2,56% 1 2,56% 0 0,00% 0 0,00%
Total 842 630 74,82% 110 13,06% 121 14,37% 45 5,34% 79 9,38% 19 2,26% 8 0,95%

































Low R&D Intensive Industries 263 217 82,51% 24 9,13% 28 10,65% 8 3,04% 10 3,80% 1 0,38% 0 0,00%
Medium Low R&D Intensive Industr 257 197 76,65% 31 12,06% 38 14,79% 16 6,23% 28 10,89% 5 1,95% 5 1,95%
Medium High R&D Intensive Indust 271 194 71,59% 42 15,50% 38 14,02% 13 4,80% 31 11,44% 7 2,58% 2 0,74%
High R&D Intensive Industries 51 22 43,14% 13 25,49% 17 33,33% 8 15,69% 10 19,61% 6 11,76% 1 1,96%
Total 842 630 74,82% 110 13,06% 121 14,37% 45 5,34% 79 45,74% 19 2,26% 8 0,95%
Note: We follow criteria used by the OECD (OECD, 2002). High-technology industries include (ISIC. 3): Aerospace, Office & computing equipment; Drugs & medicines, Radio, TV & communication equipment. Medium
Technology groups the two classes : Medium-high-technology industries (Scientific instruments, Motor vehicles, Electrical machines excl. commun. equip., Chemicals excl. drugs, Other transport, and Non-electrical
machinery) and Medium-low-technology industries (Rubber & plastic products, Shipbuilding & repairing, Other manufacturing, Non-ferrous metals, Nonmetallic mineral products, Metal products, Petroleum refineries &
products, Ferrous metals). Low-technology industries are: Paper, products & printing; Textiles, apparel & leather; food, beverages & tobacco and wood.
Note: Only Cooperation with Public Institutes: firms that declare cooperating with universities and/or public research institutes (either national and international) as the only mean of accessing scientific knowledge. Only
Use of Public sources: firms that consider public information sources as very importante for innovation (score=3). The sources of information are: from universities or other higher education institutions, government or
private non profit research institutes and from professional conferences, meeting and journals.  24





















R&D Intensity (per employee) 76.49672 210.15*** 258.46*** 191.804** 290.29** 540.31** 510.0542
Employees 122.0722 440.373*** 637,69*** 259,84 477,04** 1739,37*** 2309.125**
Turnover sales 1117340,00 5649051*** 8279243*** 3477041* 7210230** 22100000** 3.12e+07**
Turnover due to Innovation .1002181 .2010638*** 0,1851818** 0,194*** 0,15 0,2452632** .1125
Turnover due to new market introductions .0295483 .0843085*** 0,0959091*** 0,0703306** 0,082* 0,1336842* .04125
New Market Introductions 0.38 0.47 0.42 0,36 0,44 0,63 0,57
Note:  The significance of the t-tests (Pr(T<t) on the comparison of means between the group and the rest of firms lacking such a link are noted by: * at 10%, ** 5%, *** 1 
 
 
Table 4: Correlation matrix
123456789 1 0 1 1 1 2
At least one link to science 1 1.0000 
Cooperation with public institutes 2 0.7109* 1.0000 
Use of public information 3 0.7512* 0.2933* 1.0000 
Coperation and use of public info. 4 0.4357* 0.6130* 0.5800* 1.0000 
Scientific references in patents 5 0.2786* 0.1784* 0.0973* 0.1417* 1.0000 
Firms with publications 6 0.1631* 0.1653* 0.0891* 0.1807* 0.5286* 1.0000 
R&D intensity (employee) 7 0.0696 0.0673 0.0410 0.0572 0.1520* 0.0906 1.0000 
Employees 8 0.2458* 0.3190* 0.0484 0.1250* 0.4391* 0.3638* 0.0977* 1.0000 
New Market Introduction 9 0.2228* 0.1963* 0.1527* 0.1356* 0.1564* 0.0593 0.0714 0.1133* 1.0000 
Turnover sales 10 0.2303* 0.2943* 0.0675 0.1490* 0.3746* 0.3299* 0.1295* 0.7913* 0.1080* 1.0000 
Turnover due to Innovation 11 0.2001* 0.1170* 0.1424* 0.0259 0.0898* -0.0029 0.0532 0.1553* 0.2769* 0.0603 1.0000 
Turnover due to new market introductio 12 0.1808* 0.1712* 0.0957* 0.0793* 0.1138* -0.0042 0.1100* 0.0584 0.5836* 0.0451 0.5004* 1.0000 
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Table 5a: Patent quality and Types of ISL: the firm level














112 3 4 5 6
Dummy forward citation
a 0,33 0,30 0,33* 0.34* 0.34* 0.34* 0.35**
Forward Citation
b 0,67 0,70 0,67 0.69* 0.71* 0,65 0.72*
generality
b 0,10 0,09 0,10 0,10 0,10 0,09 0,10
geographical impact
b 0,22 0,14 0.188* 0,19 0,19 0,20 0.194*
Note: * significance at 10%, ** at 5%. At least one link: firms that cooperate or use public information or are involved in scientific publications. 
The forward citations contitute the number of citations received from other EPO patents. The measures of generality and geographical impact as 
well as the tests for the comparison of means (and proportions) are calculated only on the patents having received forward citations. a: Pearson 
Chi-square test on the significance of the relationship between the two groups (categorical variables); b: t-test on the significance of difference in 
 










a 0,33 0,24 0,33 4.26*
Forward Citation
b 0,67 0,64 0,67 0,193
generality
b 0,10 0,17 0,08  -2.14*
geographical impact
b 0,22 0,23 0,18  -1.14
Note: * significance at 10%, ** at 5%. The forward citations contitute the number of 
citations received from other EPO patents. The measures of generality and 
geographical impact as well as the tests for the comparison of means (and 
proportions) are calculated only on the patents having received forward citations. a: 
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Table 6: Effects of NPR and other Types of ISL on Patent Quality
Patent Indicators With NPR Without NPR With NPR Without NPR
12 3 4
Forward dummy
a 0,25 0.36** 0,22 0,27
Forward citation
b 0,71 0.72* 0,407 0,55
generality
b 0,16 0,09 0,24 0,084
geographical impact
b 0,21 0.19* 0,32 0,14
Patent Indicators With NPR Without NPR With NPR Without NPR
12 3 4
Forward dummy
a 0.27* 0.35* 0,058 0,27
Forward citation
b 0.73 0,69 0,11 0,57
generality
b 0.16
c 0,091 0,5 0,072
geographical impact
b 0,23 0,18 0,22 0,15
Patent Indicators With NPR Without NPR With NPR Without NPR
12 3 4
Forward dummy
a 0,25 0.355* 0,22 0,29
Forward citation
b 0,71 0.71* 0,407 0,57
generality
b 0,16 0,09 0,24 0,08
geographical impact
b 0,21 0.189* 0,32 0,15
Note: * significance at 10%, ** at 5%.The measures of generality and geographical impact as well as the tests for
the comparison of means are calculated only on the patents having received forward citations. a: Pearson Chi-
square test on the significance of the relationship between the two groups (categorical variables); b: t-test on the
significance of difference in the means. c: the t-test has not been calculated since there is only one observation for
patents with non patent references from firms that do not cooperate.
Firms with scientific Publications Firms without scientific Publications
Firms that cooperate with public 
institutions
Firms that do not cooperate with public 
institutions
     Firms that consider public 
sources of information as very 
important
     Firms that do not consider public 
sources of information as very 
important
 